ReviewPCN reports : psychiatry and clinical neurosciences2025
Neurofeedback: Applications, advancements, and future directions.
Review in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Neurofeedback for functional neurological disorders: future directions for research and clinical practice.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026Review
- Neurofeedback: Applications, advancements, and future directions.PCN reports : psychiatry and clinical neurosciences · 2025Review
- Evaluating the effects of multimodal EEG-fNIRS neurofeedback for motor imagery: An experimental platform and study protocol.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurofeedback, a technique enabling individuals to regulate their brain activity in real time, has gained momentum as both a clinical intervention and a tool for cognitive and performance enhancement. This review synthesizes findings from 65 studies to evaluate the current state of neurofeedback research. We outline its historical development, methodological approaches, and technological innovations, including advances in connectivity-based and multimodal feedback paradigms. Applications across clinical disorders, such as attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), depression, and autism, as well as performance optimization, are critically examined, with emphasis on efficacy, limitations, and translational challenges. To enhance transparency, we summarize methodological trends and provide integrative insights that cut across individual studies. We further discuss persistent limitations, including methodological heterogeneity and placebo-related concerns, and highlight future directions such as personalization, multimodal integration, and interdisciplinary collaboration. By consolidating evidence across diverse domains, this review positions neurofeedback as a rapidly evolving field with significant therapeutic and translational potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.